跳至主要内容
临床试验/NCT00442988
NCT00442988已完成不适用

Early Prediction of New Onset Diabetes Mellitus After Transplantation (NODAT) in Renal Transplantation: Use of Oral Glucose Tolerance Test (OGTT) and Fasting Plasma Glucose (FPG).

KU Leuven1 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2000年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
KU Leuven
入组人数
360
试验地点
1

研究概览

简要总结

A statistical analysis of the predictive value of OGTT and FPG testing executed as part of standard clinical practice after renal transplantation for the diagosis of new-onset diabetes mellitus after transplantation.

详细描述

All patients transplanted in our department receive a formal oral glucose tolerance test (and thus also fasting plasma glucose concentration) in the first week after renal transplantation. This testing for DM or Impaired Glucose Tolerance (IGT) is part of our standard clinical protocol and data are collected prospectively in all these patients in an electronic patient medical file. The development of diabetes mellitus in all transplant patients is documented, including DM therapy.

研究设计

研究类型
Observational
观察模型
Defined Population
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary or secondary single kidney transplantation
  • Age older than 18 years

排除标准

  • Pre-existing DM or documented impaired glucose metabolism
  • Combined organ transplantation

研究者

发起方
KU Leuven
申办方类型
Other

研究点 (1)

Loading locations...

相似试验